Ernexa Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Ernexa Therapeutics Inc. has filed 1,518 SEC EDGAR filings since 14 Feb 1994

SEC filing history

Showing 251-258 of 258 matching filings.

Per page
25
Current page
11
8-K File 001-11460

NTN BUZZTIME, INC.

Filing date
03 Jun 2010
Reporting date
02 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

NTN BUZZTIME, INC.

Filing date
13 May 2010
Reporting date
13 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

NTN 8-K

Filing date
21 Apr 2010
Reporting date
19 Apr 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

NTN BUZZTIME, INC.

Filing date
15 Apr 2010
Reporting date
12 Apr 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

NTN BUZZTIME, INC.

Filing date
05 Apr 2010
Reporting date
30 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

NTN BUZZTIME, INC.

Filing date
30 Mar 2010
Reporting date
30 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

CURRENT REPORT

Filing date
08 Feb 2010
Reporting date
03 Feb 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-11460

CURRENT REPORT ON FORM 8-K

Filing date
15 Jan 2010
Reporting date
15 Jan 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .